fig3

Comparison of immediate <i>vs</i>. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma

Figure 3. Kaplan-Meier estimates of overall survival comparing nephrectomy plus sunitinib vs. sunitinib alone in the CARMENA trial.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/